AbCellera Biologics Inc. (ABCL) Earnings
NASDAQ·Healthcare·Biotechnology
$5.37
+1.61%
Mkt Cap $1.75B
EPS — Estimate vs Actual
Mkt Cap
$1.75B
P/E
—
Fwd P/E
—
P/S
22.09
Rev TTM
—
EPS TTM
-$0.48
NASDAQ·Healthcare·Biotechnology
$5.37
+1.61%
Mkt Cap $1.75B
Mkt Cap
$1.75B
P/E
—
Fwd P/E
—
P/S
22.09
Rev TTM
—
EPS TTM
-$0.48